levonorgestrel has been researched along with medroxyprogesterone in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (31.88) | 18.7374 |
| 1990's | 15 (21.74) | 18.2507 |
| 2000's | 13 (18.84) | 29.6817 |
| 2010's | 16 (23.19) | 24.3611 |
| 2020's | 3 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cullins, VE | 1 |
| Crona, N; Mattsson, LA; Rybo, G; Sporrong, T; Vilbergson, G | 1 |
| Fakeye, O | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
| Christiansen, C; Marslew, U; Riis, B | 1 |
| Shaaban, MM | 1 |
| Kamau, RK; Kigondu, C; Maina, FW; Mati, JK | 1 |
| Laird, M; Monier, M | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Ayeni, O; Chalapati, S; Crawford, MA; Drury, PJ; Dusitsin, N; Gellen, JJ; Lenihan, T; Pinol, A; Sas, M; Tunkeyoon, M | 1 |
| Keller, PJ | 1 |
| Fotherby, K | 1 |
| Odlind, V | 1 |
| Fraser, IS | 1 |
| Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
| Belsey, EM | 2 |
| Belsey, EM; Peregoudov, S | 1 |
| Belsey, EM; Carlson, N; d'Arcangues, C | 1 |
| Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP | 1 |
| Affandi, B; Hadisaputra, W; Lubis, F; Moeloek, FA; Prihartono, J; Samil, RS; Santoso, SS | 1 |
| Ahlesteen, I; Astedt, B; Kjaeldgaard, A; Larsson, B | 1 |
| von Schoultz, B | 1 |
| Tiltman, AJ | 1 |
| Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
| Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 2 |
| Elstein, M; Nuttal, ID | 1 |
| Arnold, SB; Ashraf, T; Maxfield, M | 1 |
| Abdullah, N; Anwar, M; Maruo, T; Soejono, SK | 1 |
| Chambers, HM; Eckert, K; MacLennan, A; MacLennan, AH; Wenzel, S | 1 |
| Hippeläinen, M; Hulkko, S; Karppinen, K; Kupari, M; Ventilä, M; Voutilainen, S | 1 |
| Gudmundson, J; Naessen, T; Olsson, SE | 1 |
| Bouchoux, F; Degryse, M; Gaillard, M; Lecaque, D; Petit, F; Philibert, D | 1 |
| Cromer, B; Harel, Z | 1 |
| Laatikainen, T; Luotola, H; Pekonen, F; Raudaskoski, T; Riphagen, F; Ronni-Sivula, H; Tapanainen, J; Timonen, H; Tomás, E | 1 |
| Andersen, LF; Gram, J; Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 1 |
| Basta, A; Gregoraszczuk, EL; Kolodziejczyk, J; Krzysiek, J; Kurek, S; Milewicz, T; Stachura, J; Sztefko, K | 1 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Arnes, M; Maltau, JM; Straume, B; Vereide, AB; Ørbo, A | 1 |
| Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
| Shulman, LP | 1 |
| Deng, S; Lang, JH; Leng, JH; Liu, ZF; Sun, DW; Tan, XJ; Zhu, L | 1 |
| Dai, Y; Deng, S; Lang, JH; Leng, JH; Liu, ZF; Sun, DW; Tan, XJ; Zhu, L | 1 |
| Mavranezouli, I | 1 |
| Jaeger, R; Moe, BT; Orbo, A; Sager, G; Vereide, AB | 1 |
| Aboulfadl, K; Barbeau, B; Broséus, R; Daneshvar, A; Prévost, M; Sauvé, S; Vincent, S | 1 |
| Bissonnette, F; Jensen, JT; Kaunitz, AM; Lukkari-Lax, E; Monteiro, I; Muysers, C | 1 |
| Chelmow, D | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Arnes, M; Orbo, A; Pettersen, I; Straume, B; Vereide, A | 1 |
| Bahamondes, L; Bahamondes, MV; Bottura, BF; Correia, VM; Espejo-Arce, X; Fernandes, A; Gonçalves, MP; Monteiro, I; Sousa, MH | 1 |
| Hussain, M; Lethaby, A; Rees, MC; Rishworth, JR | 1 |
| Joo, WD; Ki, KD; Kim, K; Kim, MK; Kim, YH; Lee, TS; Lim, MC; Seong, SJ | 1 |
| Candido-Dos-Reis, FJ; Gonçalvez, TM; Máximo, MM; Nogueira, AA; Poli-Neto, OB; Rosa-E-Silva, JC; Silva, PS; Vieira, CS | 1 |
| Critchley, HO; Maybin, JA | 1 |
| Asl, YA; Seidi, S; Yamini, Y | 1 |
| Bae, HS; Hwang, JY; Jung, YW; Kim, DH; Kim, MK; Kim, ML; Seong, SJ; Shin, E; Yun, BS | 1 |
| Arnes, M; Lysa, LM; Moe, BT; Orbo, A; Sletten, ET; Straume, B | 1 |
| Biggs, WS; Carey, ET; McIntyre, JM | 1 |
| Li, J; Luo, B; Luo, L; Sidell, N; Zhang, H; Zheng, Y | 1 |
| Dias-da-Silva, MR; do Nascimento Verreschi, IT; Mathez, ALG; Monteagudo, PT | 1 |
| Etminan, M; Guo, MY; Khosrow-Khavar, F; Sodhi, M | 1 |
| Liu, J; Wang, L; Yu, Y; Zhou, Z | 1 |
11 review(s) available for levonorgestrel and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Injectable and implantable contraceptives.
Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone | 1992 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Adolescents: at increased risk for osteoporosis?
Topics: Adolescent; Bone Density; Contraceptive Agents, Female; Exercise; Female; Health Status; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nutritional Status; Osteoporosis; Risk Assessment; Sports | 2000 |
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
Advances in female hormonal contraception: current alternatives to oral regimens.
Topics: Contraceptive Agents, Female; Desogestrel; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone | 2003 |
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Randomized Controlled Trials as Topic | 2015 |
Medical management of heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Women's Health | 2016 |
Limited evidence guides empiric Tx of female chronic pelvic pain.
Topics: Adult; Amitriptyline; Analgesics; Chronic Pain; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Endometriosis; Evidence-Based Medicine; Female; Gabapentin; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Pain Management; Pain Measurement; Pelvic Pain; Physical Therapy Modalities | 2018 |
Oral and intrauterine progestogens for atypical endometrial hyperplasia.
Topics: Administration, Oral; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Randomized Controlled Trials as Topic | 2018 |
21 trial(s) available for levonorgestrel and medroxyprogesterone
| Article | Year |
|---|---|
An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy.
Topics: Climacteric; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Uterine Hemorrhage | 1992 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Topics: Androgen Antagonists; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norgestrel; Severity of Illness Index | 1991 |
Contraception with progestogens and progesterone during lactation.
Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology | 1991 |
The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Topics: Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Kenya; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel | 1990 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on oral contraceptives.
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Double-Blind Method; Ethinyl Estradiol; Fatty Acids; Fatty Acids, Essential; Female; Humans; Hungary; Injections; Levonorgestrel; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Thailand | 1986 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Menstruation Disturbances; Norgestrel; Patient Compliance; Patient Dropouts | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
Topics: Administration, Intravaginal; Africa; Asia; China; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Europe; Female; Humans; Latin America; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norgestrel; West Indies | 1988 |
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins | 1986 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Steroid releasing vaginal rings.
Topics: Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Medroxyprogesterone; Norethindrone; Norgestrel; Ovulation; Patient Acceptance of Health Care; Progesterone; Progestins | 1980 |
Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
Topics: Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Menstruation; Middle Aged; Norethindrone; Progestins; Prospective Studies | 1993 |
Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral; Delayed-Action Preparations; Drug Implants; Female; Forearm; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Osteocalcin; Premenopause; Progestins; Prospective Studies; Time Factors | 1995 |
Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
Topics: Administration, Intravaginal; Administration, Oral; Aged; Cholesterol, HDL; Cholesterol, LDL; Dinoprostone; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 2002 |
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Adult; Cell Nucleus; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged | 2003 |
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Middle Aged | 2010 |
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.
Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norway; Progestins; Risk; Single-Blind Method; Treatment Outcome | 2014 |
37 other study(ies) available for levonorgestrel and medroxyprogesterone
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Contraception with subdermal levonorgestrel implants as an alternative to surgical contraception at Ilorin, Nigeria.
Topics: Adolescent; Adult; Age Factors; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Drug Implants; Female; Humans; Infant, Newborn; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Nigeria; Parity; Patient Acceptance of Health Care; Sterilization, Reproductive | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Contraceptives: a look at the future.
Topics: Abortifacient Agents; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Female; Forecasting; Humans; Injections; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel; Pregnancy | 1989 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Topics: Abortion, Induced; Administration, Intravaginal; Adult; Age Factors; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norgestrel; Parity; Pregnancy; Time Factors | 1988 |
Pregnancy after removal of Norplant implants contraceptive.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy | 1987 |
Progestogen regulation of tissue plasminogen activator in a human melanoma cell line.
Topics: Ethanol; Fibrinolysis; Humans; Levonorgestrel; Medroxyprogesterone; Melanoma; Norethindrone; Norgestrel; Osmolar Concentration; Time Factors; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1988 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Topics: Adult; Blood Glucose; Castration; Contraceptives, Oral, Combined; Female; Glucose Tolerance Test; Humans; Hysterectomy; Insulin; Levonorgestrel; Lipids; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Neoplasms | 1982 |
Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
Topics: Adult; Bias; Condoms; Contraceptive Agents; Contraceptive Devices; Contraceptives, Oral; Cost-Benefit Analysis; Drug Implants; Female; Health Care Costs; Humans; Intrauterine Devices; Levonorgestrel; Male; Medroxyprogesterone; Probability; Reproducibility of Results; Sterilization, Reproductive; Sterilization, Tubal; Treatment Failure; United States; Vasectomy | 1994 |
ACOG issues report on hormonal contraception.
Topics: Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Medroxyprogesterone; Societies, Medical; United States | 1995 |
Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Topics: Adolescent; Adult; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections; Levonorgestrel; Lipids; Medroxyprogesterone | 1994 |
Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women.
Topics: Alcohol Drinking; Blood Flow Velocity; Body Mass Index; Diastole; Echocardiography, Doppler; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Levonorgestrel; Medroxyprogesterone; Menopause; Middle Aged; Reference Values; Ventricular Function, Left | 1993 |
The pharmacological profile of a novel norpregnance progestin (trimegestone).
Topics: Administration, Oral; Administration, Topical; Animals; Binding, Competitive; Endometrium; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone; Mice; Norethindrone; Norpregnenes; Progesterone Congeners; Promegestone; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Specific Pathogen-Free Organisms; Uterus | 1999 |
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Osmolar Concentration; Postmenopause; Progesterone Congeners; Progestins; Reference Values | 2002 |
Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Topics: Breast; Breast Neoplasms; Cyproterone; Female; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Levonorgestrel; Medroxyprogesterone; Norethindrone; Progesterone; Progesterone Congeners; Receptors, Estrogen | 2002 |
[Effects of medical treatment on apoptosis in eutopic endometrium of patients with endometriosis].
Topics: Apoptosis; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone | 2007 |
[Effects of progesterone and progestin on expression of regulated on activation, normal T cell expressed and secreted in eutopic endometrium from patients with endometriosis].
Topics: Cells, Cultured; Chemokine CCL5; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Progesterone; Progestins; Transforming Growth Factor alpha | 2007 |
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Decision Trees; Desogestrel; Drug Administration Routes; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone; Models, Theoretical; Practice Guidelines as Topic; Sterilization, Tubal; Time Factors; United Kingdom | 2008 |
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Synergism; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Medroxyprogesterone; Mifepristone; Progesterone; Progestins; Receptors, Progesterone | 2009 |
Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.
Topics: Caffeine; Endocrine Disruptors; Estradiol; Estriol; Estrogens; Estrone; Hydrogen-Ion Concentration; Levonorgestrel; Medroxyprogesterone; Molecular Structure; Norethindrone; Oxidation-Reduction; Ozone; Pesticides; Pharmaceutical Preparations; Progesterone; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |
Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Progestins | 2010 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Topics: Brazil; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Pregnancy; Pregnancy, Unplanned; Quality-Adjusted Life Years; Retrospective Studies; Time Factors | 2014 |
Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
Topics: Adult; Biopsy, Fine-Needle; Contraceptive Agents, Female; Curettage; Endometrial Hyperplasia; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Prospective Studies; Republic of Korea | 2015 |
Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Drug Implants; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Medroxyprogesterone; Menstrual Cycle; Pain Measurement; Pain Threshold; Pressure; Progesterone; Progestins; Psychometrics; Surveys and Questionnaires; Testosterone; Young Adult | 2015 |
Development of a microfluidic-chip system for liquid-phase microextraction based on two immiscible organic solvents for the extraction and preconcentration of some hormonal drugs.
Topics: Adult; Alkanes; Dydrogesterone; Female; Humans; Lab-On-A-Chip Devices; Levonorgestrel; Liquid Phase Microextraction; Medroxyprogesterone; Methanol; Polymethyl Methacrylate; Solvents | 2016 |
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
Topics: Administration, Oral; Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2017 |
Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.
Topics: Administration, Oral; Adult; Aged; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Receptors, Progesterone; Recurrence | 2017 |
Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone; Progestins; Retrospective Studies; Treatment Outcome; Turner Syndrome; Weight Gain; Young Adult | 2020 |
Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Sexual Dysfunction, Physiological; Young Adult | 2021 |
Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding.
Topics: Female; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Perimenopause; Quality of Life; Uterine Hemorrhage | 2022 |